A non extraction HPLC method is described for the simultaneous measurement of theophylline and caffeine in human serum using a Pinkerton> ISRP column and u.v. detection at 275 nrn. The method is suitable for therapeutic monitoring of theophylline levels in adults and, in particular, quantitation of both theophylline and caffeine in premature neonates where as little as 10 J-IL of sample can be used. Comparison of theophylline levels obtained by this method with EMIT analysis show a correlation coefficient of 0·97 (n=37) in adults and 0·79 (n= 16) in premature neonates. There was no correlation between serum theophylline and caffeine levels in premature neonates receiving theophylline therapy. No interference was encountered from endogenous plasma components or other drugs in the 53 patients studied. Precision of the assays compares well with reported values for extraction HPLC and immunochemical analyses.
SUMMARY. A non extraction HPLC method is described for the simultaneous measurement of theophylline and caffeine in human serum using a Pinkerton> ISRP column and u.v. detection at 275 nrn. The method is suitable for therapeutic monitoring of theophylline levels in adults and, in particular, quantitation of both theophylline and caffeine in premature neonates where as little as 10 J-IL of sample can be used. Comparison of theophylline levels obtained by this method with EMIT analysis show a correlation coefficient of 0·97 (n=37) in adults and 0·79 (n= 16) in premature neonates. There was no correlation between serum theophylline and caffeine levels in premature neonates receiving theophylline therapy. No interference was encountered from endogenous plasma components or other drugs in the 53 patients studied. Precision of the assays compares well with reported values for extraction HPLC and immunochemical analyses.
Theophylline is widely used for the treatment of acute and chronic airflow obstruction in adults and children and for the treatment of apnoeic attacks in neonates. I In adults the therapeutic effect of theophylline on bronchodilation appears to be directly proportional to the logarithm of the plasma concentration above 27 J-Imol/L.2 Toxic side effects may occur above 110 J-Imol/L which may be life threatening should levels attain 220-275 J-Imol/L.3 In all but the premature neonate caffeine is metabolised to theophylline which is further metabolised by N-demethylation to form 3-methyl xanthine, 1,3-dimethyl uric acid and 1methyl uric acid; however in the premature neonate transformation of theophylline to caffeine occurs." Caffeine administration alone has been shown to reduce apnoeic attacks in neonates" and is probably equipotent to theophylline. 5 . 6 The measurement of serum theophylline concentrations in those receiving therapy and caffeine concentrations in the neonate is thus recommended to avoid life-threatening events." 7 Serum theophylline concentrations have been measured by spectrophotometric assays", gas liquid chromatography (GLC)9, radioimmunoassay!" and non-isotopic immunochemical techniques.'! 12 Interference by non-active metabolites in immunochemical assays can be a problem, and this has been reported in patients with renal Correspondence: S. J. Rainbow. failure. 13 Monoclonal antibodies appear to reduce the interference but do not eliminate it completely. 14 A variety of HPLC methods for the simultaneous measurement of theophylline and caffeine'>" have been described using reversed phase (C I8 ) columns after extraction into organic solvents followed by evaporation and subsequent reconstitution in the mobile phase.": 16 More recently Bond Elut" columns have been used for the extraction of theophylline and caffeine from serum prior to HPLC analysis."
We describe a new non-extraction HPLC method for the simultaneous measurement of theophylline and caffeine in human serum using a Pinkerton?" Internal Surface Reverse Phase (ISRP) column." Materials and methods REAGENTS Methanol (Hypersolve), potassium dihydrogen phosphate and dipotassium hydrogen phosphate were obtained from BDH Ltd, Poole, UK. Theophylline, theobromine, caffeine, 7-hydroxyethyl theophylline, 7-hydroxypropyl theophylline, xanthine, hypoxanthine and uric acid were obtained from Sigma Chemical Company Ltd, Poole, UK. Pharmaceutical preparations of cefuroxime, ceftazidime (Glaxo Laboratories, Greenford, UK), cefoxitin (Merck, Sharp and Dohme Ltd, Hoddesdon, UK) and cefotaxime (Roussel Laboratories Ltd, Uxbridge, UK) were obtained through the hospital pharmacy. Human serum standards and quality control material for theophylline and caffeine were obtained from Syva UK, Maidenhead, UK. These were used to check the spiked human serum or aqueous standards used routinely.
APPARATUS
The high performance liquid chromatography system consisted of a LC-XD pump and LC-UV variable wavelength detector (Pye-Unicam, Phillips Analytical Department, Cambridge, UK). Flow cell volume was 8 JlL and light path was 1 cm. Sample injection was achieved with an auto injector model SpH125 Fix (Spark Holland, Emmen, Netherlands) or a manual Rheodyne valve. Signal output was monitored on a SP4100 computing integrator (Spectraphysics, Santa Clara, California, USA).
CHROMATOGRAPHY
The chromatographic separation was achieved using either a 25 em or a 15 em Pinkerton> ISRP column (Orbit Laboratories, Bangor, UK) at ambient temperature with an isocratic eluant of 0·1 molJL potassium phosphate buffer (pH 6,8) containing 3% methanol (flow rate 0·6 ml.jrnin) for the 25 em column or no methanol (flow rate 0·5 mL/min) for the 15 em column. A disposable cartridge column of the same material preceded the main columns. The columns and precolumns were stored in acetonitrile and washed with distilled water for 5 min and then eluant buffer for 10 min prior to use. The precolumn was changed after 400 injections. The 25 em column has received in excess of 2000 injections without any appreciable increase in back pressure or decrease in resolution. The flow direction through the analytical column was reversed regularly. A 10 
Results
Resolution ofinternal standard, theophylline and caffeine was achieved using the conditions described and analysis was completed within 16min for the 25 cm column (Fig. I) or 10 min for the 15 em column (Fig. 2) . Increasing the flow rate or increasing the methanol concentration decreased the retention times but also decreased resolution with resulting loss of separation and interference from cephalosporin antibiotics was noted in neonatal samples. However, under the running conditions described the four cephalosporin antibiotics tested ran significantly ahead of the internal standard peak (Table I) . Retention indices (RIs) relative to the internal standard (7-(2hydroxyethyl)-theophylline) for a series of endogenous xanthine-like compounds, synthetic theophylline analogues and two common analgesics are also shown in Table I . Serum from a female volunteer taking no drug therapy showed no significant interfering endogenous peaks ( Intra-assay coefficients of variation for theophylline were 2'4%, 1·6% and 2·1% at concentrations of29·5 Jlmol/L, 73·9 J.lIDol/L and 93·6 Jlmol/ L (n = 10), respectively. For caffeine the intraassay CVs (n= 10) were 4,8%,3'7% and 3·8% at 16·3 Jlmol/L, 42·0 Jlmol/L and 62·9 Jlmol/L, respectively. The inter-assay CV% for theophylline was 3·6% at 82·3 Jlmol/L (n= 10) and for caffeine was 5·4% at 62·6 umol/L (n= 10). Dilution of eight patients' samples containing theophylline (range 31-103 Jlmol/L) with 0·15 rnol/L sodium chloride (1: 1) gave results of 102±2% of the original value after correction for dilution.
The results obtained by this direct injection HPLC method for theophylline showed a good 3) using peak height ratios of compound to internal standard. Calibration curves for aqueous standards were coincident with the serum-based ones, with recoveries of between 96% and 103%. Similar recoveries were obtained from serum with high bilirubin (total bilirubin of 20Q-400Jlmol/L) and from saponin-haemolysed whole blood. 
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Discussion peptidase A but the internal surface tripeptide is uncleaved because the peptidase is too large to enter the pores of the silica. The resulting packing material is Hypersil with hydrophilic external surfaces and hydrophobic internal surfaces. In our experience, the ISRP column packing is variable from batch to batch so each new column must be assessed for separation of the compounds of interest, since chromatographic conditions may vary considerably (Figs 1 and 2) . Indeed, on one 25 em column, paracetamol and salicylate cochromatographed with theophylline and caffeine, respectively, whereas resolution was achieved on the columns used in this work (Table I) . Nevertheless, the ISRP colums offer advantages over previously reported HPLC methods for theophylline and caffeine in that no sample or column preparation is necessary, the serum being simply diluted with internal standard and then injected onto the column. Interference from proteins is not a problem because they are eluted early, before the compounds of interest. Small sample volumes (10 JlL) as well as the simultaneous estimation of caffeine and theophylline make the method especially suitable for specimens from neonates. Theophylline results obtained by this method correlate well with those produced by EMIT analysis in adults (r = 0'97) but slightly less well in neonates (r = 0'79). The demonstrated lack of correlation between theophylline and caffeine levels in the neonatal samples emphasises the need to measure both drugs in such samples.
The potential problem of interference from other drugs has to be considered when analysing unextracted serum. Of the 53 patients' samples analysed in this study, no interference from other drugs was encountered. Cephalosporin antibiotics have been reported to interfere with extraction methods for theophylline'? but the four cephalosporins tested on the ISRP columns eluted before the internal standard peak, the first of the peaks of interest. The time of 16 min taken to complete the analysis of both theophylline and caffeine on the 25 ern column is reduced to only 10 minutes on the 15 em column.
Reproducibility of the analyses was good with interassay coefficients of variation for theophylline (82,3 Jlmol/L) and caffeine (62'6 Jlmol/L) of 3·6% and 5·4% respectively, which compare well with extraction HPLC analysis for theophylline l S -17 and caffeine. 16, 17 Use of the Pinkerton?' ISRP column offers an interference free, non-extraction HPLC method which is simple, precise and requires as little as 10 JlL of sample for the simultaneous measurement of caffeine and theophylline, making the method High performance liquid chromatography of theophylline and caffeine in biological fluids using reverse phase chromatographic packing material generally requires precipitation, extraction or adsorption to remove plasma proteins.P:" The ISRP packing material provides a new concept in HPLC column technology", It uses the basic principles of size exclusion chromatography, the column-support material being made of porous rigid silica particles, the pores of which have an exclusion size of about 2000 daltons. Plasma and serum proteins are excluded and pass through the spaces around the non-absorbent outer surfaces of the particles. During preparation of the ISRP material, the Hypersil 5 Jlm silica particles are coated with a giycerylpropyl group (hydrophilic phase) to which is bonded a tripeptide, glycyl-phenylalanyl-phenylalanine (hydrophobic phase). The tripeptide on the external surface of the particle is cleaved by carboxy-correlation (r= 0,97, p < 0'001, n = 37) with those obtained by EMIT assay in adult patients (Fig. 4) . The slope of the regression line was 0·91 with an intercept of 3 Jlmol/L. No significant caffeine peak was seen in this group of patients. Comparison of theophylline results in 16 premature infants showed a correlation of r=0·79 (P < 0·00 I) between the HPLC and EMIT analyses. Caffeine levels were recorded simultaneously with the theophylline results on the infants and a mean level of 12·3 ±4·5 Jlmol/L was obtained with a range of 4-23 Jlmol/L. Regression analysis of the theophylline and caffeine leveis in infants showed no correlation (Fig. 5 ). In the patients studied there were no interfering peaks observed in the region of either the internal standard, theophylline or caffeine. suitable for monitoring neonates receiving either theophylline or caffeine therapy as well as adults receiving theophylline therapy.
